The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish Land Regulatory News (BLND)

Share Price Information for British Land (BLND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 422.60
Bid: 420.60
Ask: 421.60
Change: 13.20 (3.22%)
Spread: 1.00 (0.238%)
Open: 412.00
High: 422.60
Low: 410.80
Prev. Close: 409.40
BLND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Clarges

18 Nov 2020 07:01

RNS Number : 6490F
British Land Co PLC
18 November 2020
 

 

British Land agrees sale of Clarges, Mayfair to Deka for £177m

18 November 2020

British Land is pleased to announce it has completed on the sale of Clarges Mayfair to Deka for £177m, 7.6% above the September 2020 valuation.

Clarges represents a landmark mixed-use development for British Land. The site was acquired in 2012 and the redevelopment was completed in 2017, delivering over 50,000 sq ft of world class office space, 34 super prime residential apartments and nearly 15,000 sq ft of high quality retail. It is an excellent example of creating value through the strength and depth of our capabilities, across planning, development, asset management, leasing and investment.

Simon Carter, incoming CEO at British Land, said: "Clarges is a fantastic example of our ability to create outstanding mixed-use places and drive value through development. The sale is in line with our focus on active capital management, recycling out of more mature assets and positioning us to progress our value accretive London development pipeline, focused on our mixed use campuses and Canada Water."

The offices and retail space are fully let, with retail occupiers including Le Comptoir Robuchon, Le Deli Robuchon and a Porsche showroom.

Deka was advised by Savills and Simmons & Simmons, and British Land was advised by CBRE and Mayer Brown.

Enquiries:

Investors & Analysts: David Walker 07753 928 382

Media: Charlotte Whitley 07887 802 535

Notes to Editors

About British Land

Our portfolio of high quality UK commercial property is focused on London Offices and Retail around the UK. We own or manage a portfolio valued at £13.7bn (British Land share: £10.3bn) as at 30 September 2020 making us one of Europe's largest listed real estate investment companies.

Our strategy is to provide places which meet the needs of our customers and respond to changing lifestyles - Places People Prefer. We do this by creating great environments both inside and outside our buildings and use our scale and placemaking skills to enhance and enliven them. This expands their appeal to a broader range of occupiers, creating enduring demand and driving sustainable, long term performance.

Our Offices portfolio comprises three office-led campuses in central London as well as high quality standalone buildings and accounts for 65% of our portfolio. Our Retail portfolio is focused on retail parks and shopping centres, and accounts for 31% of our portfolio. Increasingly our focus is on providing a mix of uses and this is most evident at Canada Water, our 53 acre redevelopment opportunity where we have plans to create a new neighbourhood for London.

Sustainability is embedded throughout our business. Our places, which are designed to meet high sustainability standards, become part of local communities, provide opportunities for skills development and employment and promote wellbeing. In April 2016 British Land received the Queen's Award for Enterprise: Sustainable Development, the UK's highest accolade for business success for economic, social and environmental achievements over a period of five years.

Further details can be found on the British Land website at www.britishland.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFFILLVLDLII
Date   Source Headline
27th Jun 20232:00 pmRNSDirector/PDMR Shareholding
23rd Jun 20231:00 pmRNSDirector/PDMR Shareholding
19th Jun 20232:16 pmRNSHolding(s) in Company
16th Jun 202311:00 amRNSDirector/PDMR Shareholding
15th Jun 202312:00 pmRNSDirector/PDMR Shareholding
14th Jun 202312:00 pmRNSHolding(s) in Company
13th Jun 202312:00 pmRNSHolding(s) in Company
9th Jun 20233:54 pmRNSAnnual Financial Report
9th Jun 20232:00 pmRNSHolding(s) in Company
8th Jun 20232:00 pmRNSHolding(s) in Company
2nd Jun 202310:00 amRNSDirector/PDMR Shareholding
31st May 20233:00 pmRNSTotal Voting Rights
30th May 20237:00 amRNSDirector/PDMR Shareholding
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSDirector/PDMR Shareholding
19th May 20232:00 pmRNSHolding(s) in Company
17th May 20237:00 amRNSFinal Results
16th May 202312:00 pmRNSDirector/PDMR Shareholding
5th May 20233:00 pmRNSHolding(s) in Company
28th Apr 20231:29 pmRNSTotal Voting Rights
18th Apr 20232:15 pmRNSDirector/PDMR Shareholding
11th Apr 202311:00 amRNSBlock listing Interim Review
11th Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 202310:00 amRNSHolding(s) in Company
31st Mar 20239:00 amRNSTotal Voting Rights
30th Mar 20233:53 pmRNSHolding(s) in Company
29th Mar 202312:00 pmRNSHolding(s) in Company
16th Mar 20233:30 pmRNSDirector/PDMR Shareholding
10th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Feb 20232:00 pmRNSTotal Voting Rights
15th Feb 20234:00 pmRNSDirector/PDMR Shareholding
31st Jan 202312:57 pmRNSTotal Voting Rights
17th Jan 20231:56 pmRNSDirector/PDMR Shareholding
10th Jan 202312:00 pmRNSDirector/PDMR Shareholding
5th Jan 20232:00 pmRNSDirector/PDMR Shareholding
30th Dec 20229:55 amRNSTotal Voting Rights
16th Dec 20222:30 pmRNSDirector/PDMR Shareholding
30th Nov 20223:00 pmRNSTotal Voting Rights
18th Nov 20227:10 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year Report
15th Nov 202212:00 pmRNSDirector/PDMR Shareholding
31st Oct 20223:52 pmRNSDirector/PDMR Shareholding
31st Oct 20223:31 pmRNSTotal Voting Rights
18th Oct 20222:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:00 pmRNSBlock listing Interim Review
30th Sep 202212:00 pmRNSTotal Voting Rights
16th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 20223:30 pmRNSDirector/PDMR Shareholding
31st Aug 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.